{"id":"https://genegraph.clinicalgenome.org/r/3182cfde-2d47-4cd2-b478-6f6f8185b5dav2.2","type":"EvidenceStrengthAssertion","dc:description":["*CA8* was first reported in relation to autosomal recessive cerebellar ataxia in 2009 (Turkmen et al., PMID: 19461874). *CA8*-related cerebellar ataxia is characterized by features of cerebellar ataxia such as wide-based or quadrupedal gait, intention tremor, dysarthria, cerebellar atrophy, and developmental delay with or without cognitive delay (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436). Six variants (5 missense and 1 truncating) that have been reported in 12 individuals (6 probands) in 6 publications (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436) are included in this curation. The mechanism of pathogenicity appears to be loss of function.\n\nThis gene-disease relationship is also supported by experimental evidence. The ataxic mouse model 'Rigoletto' (rig) carries a 19-bp deletion in *Car8*, the mouse homolog of *CA8*. Studies of cerebellar Purkinje cells in these mice showed decreased spontaneous excitatory transmission with a reportedly lower number of functional synapses. Mutants also showed abnormalities of the extension of climbing fibers to distal Purkinje cell dendrites, of parallel fibers and dendritic spines (including free spines that did not form normal synapses), and multiple synaptic varicosities. The authors concluded that Car8 plays a critical role in synaptogenesis and/or maintenance of proper synaptic morphology and function in the cerebellum (PMID: 17376701). Expression studies also indicated specific expression of CAR8 in cerebellar Purkinje cells and minimal to absent expression in the spinal cord and cerebral cortex (PMIDs: 16118194, 31693170).\n\nIn summary, there is moderate evidence supporting the relationship between *CA8* and autosomal recessive cerebellar ataxia. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Autism and Intellectual Disability Gene Curation Expert Panel on January 16, 2024 (SOP Version 10).","*CA8* was first reported in relation to autosomal recessive cerebellar ataxia in 2009 (Turkmen et al., PMID: 19461874). *CA8*-related cerebellar ataxia is characterized by features of cerebellar ataxia such as wide-based or quadrupedal gait, intention tremor, dysarthria, cerebellar atrophy, and developmental delay with or without cognitive delay (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436). Six variants (5 missense and 1 truncating) that have been reported in 12 individuals (6 probands) in 6 publications (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436) are included in this curation. The mechanism of pathogenicity appears to be loss of function.\n\nThis gene-disease relationship is also supported by experimental evidence. The ataxic mouse model 'Rigoletto' (rig) carries a 19-bp deletion in *Car8*, the mouse homolog of *CA8*. Studies of cerebellar Purkinje cells in these mice showed decreased spontaneous excitatory transmission with a reportedly lower number of functional synapses. Mutants also showed abnormalities of the extension of climbing fibers to distal Purkinje cell dendrites, of parallel fibers and dendritic spines (including free spines that did not form normal synapses), and multiple synaptic varicosities. The authors concluded that Car8 plays a critical role in synaptogenesis and/or maintenance of proper synaptic morphology and function in the cerebellum (PMID: 17376701). Expression studies also indicated specific expression of CAR8 in cerebellar Purkinje cells and minimal to absent expression in the spinal cord and cerebral cortex (PMIDs: 16118194, 31693170).\n\nIn summary, there is moderate evidence supporting the relationship between *CA8* and autosomal recessive cerebellar ataxia. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on January 16, 2024 (SOP Version 10)."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3182cfde-2d47-4cd2-b478-6f6f8185b5da","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd","calculatedEvidenceStrength":"Moderate","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2024-01-16T17:00:00.000Z","2024-01-15T23:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-08-18T09:58:28.668Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f3feba0-6bbd-470f-b4dc-57542ccdea3c","type":"EvidenceLine","dc:description":"Per latest SOP, points awarded to expression are 0.5.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31bea59e-8b4b-4b77-9683-14dffa4758ac","type":"Finding","dc:description":"Waddles mice: Immunohistochemically, CAR8 expression was greatest in cerebellar Purkinje cells and minimal to absent in the spinal cord and cerebral cortex. In line with the Western blotting results, CAR8 expression was virtually undetectable in wdl mice.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16118194","rdfs:label":"IHC","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c78b26bc-6c92-4f13-9668-7381d5fa40e0","type":"EvidenceLine","dc:description":"In vitro studies show the “G” allele (CA8-204G) produces a stable peptide that inhibits ITPR1 activation and Ca++ release in non-neuronal cells, but not in neuronal cells. This experiment is NOT relevant to function being discussed in the realm of this disease. \n","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a29eb507-38df-47c2-aa16-a805e69fcc03","type":"Finding","dc:description":"CA8-204G transcript expression occurred predominantly in non-neuronal cells (HEK293), while CA8-204C expression was restricted to neuronal derived cells (NBL) in vitro. CA8-204G produced a stable truncated transcript in HEK293 cells that was barely detectable in NBL cells. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31199789","rdfs:label":"Alternative splicing of DRG CA8-204","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfc13a82-6fdc-4f9b-ac27-05281139a9d1","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5d7d772-fe34-46bd-abab-fc6e52249f6a","type":"Finding","dc:description":"The ataxic mouse model 'Rigoletto' (rig) mutant mouse carries a 19-bp deletion in Car8, the mouse homolog of CA8. Studies of cerebellar Purkinje cells in these mice showed decreased spontaneous excitatory transmission with a reportedly lower number of functional synapses. Mutants also showed abnormalities of the extension of climbing fibers to distal Purkinje cell dendrites, of parallel fibers and dendritic spines (including free spines that did not form normal synapses), and multiple synaptic varicosities. Authors concluded that Car8 plays a critical role in synaptogenesis and/or maintenance of proper synaptic morphology and function in the cerebellum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17376701","rdfs:label":"Analyses of mouse cerebellum carrying a Car8 mutation","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b136b7c-63ea-4c5c-b137-948adb5f6c67_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b136b7c-63ea-4c5c-b137-948adb5f6c67","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31693170","rdfs:label":"9y Male ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/93f039a8-68f1-4410-81bf-c3436ff82676","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004056.6(CA8):c.232C>T (p.Arg78Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371396130"}},"detectionMethod":"Proband only","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001310","obo:HP_0002194","obo:HP_0001251","obo:HP_0002078","obo:HP_0002311","obo:HP_0001260","obo:HP_0001272","obo:HP_0002136","obo:HP_0002080"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0629060e-196c-4500-8d21-716ad9b93d3d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31693170","allele":{"id":"https://genegraph.clinicalgenome.org/r/93f039a8-68f1-4410-81bf-c3436ff82676"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/0629060e-196c-4500-8d21-716ad9b93d3d","type":"EvidenceLine","dc:description":"Per ID/A scoring guidelines, the score for this proband is capped at 2.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0629060e-196c-4500-8d21-716ad9b93d3d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b8da6471-8314-4fa3-a986-02ca5df71138_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8da6471-8314-4fa3-a986-02ca5df71138","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21937992","rdfs:label":"M107","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce4b715a-57c4-4da2-b4de-d526cd35c606","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004056.6(CA8):c.710G>A (p.Arg237Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA128507"}},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/107ba811-8e79-493e-8792-3f12048b40f8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21937992","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce4b715a-57c4-4da2-b4de-d526cd35c606"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/107ba811-8e79-493e-8792-3f12048b40f8","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/107ba811-8e79-493e-8792-3f12048b40f8_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/9507c9c9-a408-4980-bee6-1cae2c899fda_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9507c9c9-a408-4980-bee6-1cae2c899fda","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27217339","rdfs:label":"Case ID61","ageType":"AgeAtReport","allele":{"id":"https://genegraph.clinicalgenome.org/r/63c8a688-ac12-466f-a3cb-9333ada465f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004056.6(CA8):c.479C>T (p.Pro160Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4758880"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0002497","previousTesting":true,"previousTestingDescription":"SPG11 testing was negative","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/44eec9bf-410c-49ef-b377-51610bdfba85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27217339","allele":{"id":"https://genegraph.clinicalgenome.org/r/63c8a688-ac12-466f-a3cb-9333ada465f9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/44eec9bf-410c-49ef-b377-51610bdfba85","type":"EvidenceLine","dc:description":"A total score of 0.1 awarded as the proband may be too young to express full extent of the phenotype.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44eec9bf-410c-49ef-b377-51610bdfba85_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e197bee1-a301-407a-a571-c28bc1bee62d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e197bee1-a301-407a-a571-c28bc1bee62d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21812104","rdfs:label":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5de2dc13-2455-4c0e-b708-6b8caa94d8fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004056.6(CA8):c.484G>A (p.Gly162Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371397575"}},"detectionMethod":"The linkage analysis revealed a high logarithm of the odds (LOD) score region on 8q that harbors the CA8 in which a novel homozygous c.484G>A (p.G162R) mutation was identified in all seven affected members. ","firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0002080","obo:HP_0002518","obo:HP_0002362","obo:HP_0001260","obo:HP_0001251","obo:HP_0001270","obo:HP_0000639","obo:HP_0100543","obo:HP_0002136"],"previousTesting":false,"previousTestingDescription":"The patients had variable cerebellar ataxia and mild cognitive impairment without quadrupedal gait. The brain MRI showed variable cerebellar volume loss and ill‐defined peritrigonal white matter abnormalities. ","secondTestingMethod":"Homozygosity mapping","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e83f919f-25a3-4e6a-8ff5-17b919415742_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21812104","allele":{"id":"https://genegraph.clinicalgenome.org/r/5de2dc13-2455-4c0e-b708-6b8caa94d8fb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/e83f919f-25a3-4e6a-8ff5-17b919415742","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e83f919f-25a3-4e6a-8ff5-17b919415742_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/576adf2b-dd02-4a15-ac1b-a805f6316bb2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/576adf2b-dd02-4a15-ac1b-a805f6316bb2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19461874","rdfs:label":"II-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/75526330-c2a6-4eb4-b24e-1dcbd3c0ae17","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004056.6(CA8):c.298T>C (p.Ser100Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127301"}},"detectionMethod":"The family was genotyped using the Affymetrix GeneChip® Human Mapping 10 K Array. ","firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0009878","obo:HP_0001260","obo:HP_0001256","obo:HP_0001337"],"previousTesting":false,"secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/687f4b70-cfed-49b9-a0d1-82e3fe2660fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19461874","allele":{"id":"https://genegraph.clinicalgenome.org/r/75526330-c2a6-4eb4-b24e-1dcbd3c0ae17"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/687f4b70-cfed-49b9-a0d1-82e3fe2660fc","type":"EvidenceLine","dc:description":"Functional evidence is not scored because it doesn’t indicate that the variant impacts protein function.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/687f4b70-cfed-49b9-a0d1-82e3fe2660fc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/687f4b70-cfed-49b9-a0d1-82e3fe2660fc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence in HEK293T cells: mRNA levels were equal ( WT vs mutant) but protein levels were reduced for the transfected cells on tetracycline induction and rescued by using MG132, a proteasome inhibitor\n","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/59ad70b3-5837-48ab-bb60-d87cb99feb9d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59ad70b3-5837-48ab-bb60-d87cb99feb9d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32808436","rdfs:label":"11 years old girl","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/54d44c2e-0a6d-4a22-8844-29bb9da59608","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004056.6(CA8):c.251A>G (p.Asn84Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4758936"}},"detectionMethod":"A clinical exome analysis identified a novel homozygous c.251A > G (p.Asn84Ser) likely pathogenic variant in the carbonic anhydrase 8 (CA8) gene. ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"suspected focal seizures, controlled by valproic acid, severe static - kinetic cerebellar syndrome, walking without support is possible for short distances only. Strikingly, three consecutive MRIs did not show any sign of cerebellar abnormalities, but a brain positron emission tomography (PET) using [18F]-fluorodeoxyglucose (FDG) demonstrated a clear decrease in glucose metabolism in the cerebellum as well as the anterior and medial temporal lobe bilaterally.","phenotypes":["obo:HP_0001249","obo:HP_0007359"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ac1ba878-1321-4bd8-aa15-7164e5e92278_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32808436","allele":{"id":"https://genegraph.clinicalgenome.org/r/54d44c2e-0a6d-4a22-8844-29bb9da59608"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/ac1ba878-1321-4bd8-aa15-7164e5e92278","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac1ba878-1321-4bd8-aa15-7164e5e92278_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/a0800c48-e3b1-4cb2-bbd1-4d649e506ebd_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41d89111-1193-4d46-b4fd-761415459e0e_proband_segregation","type":"FamilyCosegregation","dc:description":"no pedigree provided, but plenty of other evidence that multiple individuals were genotyped, see fig.3","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21812104","rdfs:label":"The large consanguineous family","estimatedLodScore":3.03,"family":{"id":"https://genegraph.clinicalgenome.org/r/41d89111-1193-4d46-b4fd-761415459e0e","type":"Family","rdfs:label":"The large consanguineous family","member":{"id":"https://genegraph.clinicalgenome.org/r/e197bee1-a301-407a-a571-c28bc1bee62d"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e197bee1-a301-407a-a571-c28bc1bee62d"},"publishedLodScore":5.1,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3edcb715-28b4-4d83-9071-68453ff6b795_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19461874","rdfs:label":"The Iraqi Family, consanguineous","family":{"id":"https://genegraph.clinicalgenome.org/r/3edcb715-28b4-4d83-9071-68453ff6b795","type":"Family","rdfs:label":"The Iraqi Family, consanguineous","member":{"id":"https://genegraph.clinicalgenome.org/r/576adf2b-dd02-4a15-ac1b-a805f6316bb2"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001256","obo:HP_0009878","obo:HP_0001260","obo:HP_0001337"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/576adf2b-dd02-4a15-ac1b-a805f6316bb2"},"publishedLodScore":3.01,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/9a83ac0e-34f0-48a4-abdb-7740f0af4295_proband_segregation","type":"FamilyCosegregation","dc:description":"The LOD score was not included for segregation calculations because of the absence of a pedigree and because of the presence of an additional area of linkage disequilibrium found on chromosome 21 (chr21:22,826,949-37,196,902, chr 21q21.1 q22.12= 90 protein coding genes like SON, RUNX1, KCNE1, MRAP, CFAP298)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21937992","rdfs:label":"M107","estimatedLodScore":2.06,"family":{"id":"https://genegraph.clinicalgenome.org/r/9a83ac0e-34f0-48a4-abdb-7740f0af4295","type":"Family","rdfs:label":"M107","member":{"id":"https://genegraph.clinicalgenome.org/r/b8da6471-8314-4fa3-a986-02ca5df71138"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001256","obo:HP_0001251"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b8da6471-8314-4fa3-a986-02ca5df71138"},"publishedLodScore":2.4}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":4.4}],"evidenceStrength":"Moderate","sequence":11281,"specifiedBy":"GeneValidityCriteria10","strengthScore":6.9,"subject":{"id":"https://genegraph.clinicalgenome.org/r/asT58nsXWos","type":"GeneValidityProposition","disease":"obo:MONDO_0000437","gene":"hgnc:1382","modeOfInheritance":"obo:HP_0000007"},"version":"2.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a0800c48-e3b1-4cb2-bbd1-4d649e506ebd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}